Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012

Publication Date	December 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	105
ISBN Number	not applicable
Product Code	GMD07844

Buy this product or for assistance call +44 20 7060 7474

PDF £2,105.00$3501 | €2356

FAX Order above formats by FAX

Summary

Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012

Summary

Increased R&D expenses and anemic product pipeline coupled with tightening regulatory hurdles have forced the leading medical equipment manufacturers to revamp their business strategies. Given the ever-expanding competitive landscape, real-time intelligence on the market potential, market scope and market penetration of key competitor pipeline products will help the leading market players to re-asses their competitive strategies. Global Markets Direct's Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012 report provides insightful information and analysis on products and technologies that are expected to bring a significant shift to the prevalent market landscape. While the focus is to identify and review the products, the report goes further down by predicting the expected launch and market potential. The report also identifies and reviews the existing competing technologies and the likely impact of the launch on the competitive landscape. Essentially, the report serves as an ideal source of information and insight for all the stakeholders within the global medical equipment market.

Scope

The report provides analysis and review of the key pipeline devices that will impact the device based treatment landscape globally and includes Nucleus Replacement, Bioabsorbable Stents, Deep Brain Stimulation, Negative Pressure Wound Therapy (NPWT), Tomosynthesis and Biologics Delivery.
The report provides market size data for Nucleus Replacement, Bioabsorbable Stents, Deep Brain Stimulation, and Negative Pressure Wound Therapy (NPWT).
Annualized market revenues data from 2000 to 2007, forecast forward for 5 years to 2012.
The report covers information on product details, indication details and clinical trial status with projections on the market potential.
The report also reviews and analyses the trends shaping and defining the markets that the products are being targeted in.
Key topics covered in the report include the device-specific developments, M&A landscape and strategic partnerships expected to influence the launch and market penetration.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to buy

Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
Stay ahead of the information curve in the fast changing medical equipment sector.
Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Content

Table of Contents
1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is this Report About?
- 2.1.1 Key technologies covered:
2.2 Definitions
- 2.2.1 Cardiovascular Devices
- 2.2.2 Orthopedic Devices
- 2.2.3 Diagnostic Imaging
- 2.2.4 Ophthalmic Devices
- 2.2.5 In-vitro Diagnostics
- 2.2.6 Patient Monitoring Devices
- 2.2.7 Dental Devices
- 2.2.8 Endoscopy Devices
- 2.2.9 Hospital Supplies
- 2.2.10 Nephrology and Urology Devices
- 2.2.11 Diabetes Care Devices
- 2.2.12 Wound Care Management
- 2.2.13 Neurology Devices
- 2.2.14 Surgical Equipment
- 2.2.15 Anesthesia and Respiratory Devices
- 2.2.16 ENT Devices
- 2.2.17 Drug Delivery Devices
- 2.2.18 Healthcare IT
3 Executive Summary
4 Key Pipeline Technologies A Preface
5 Nucleus Replacement- A Promising Technology
5.1 Spinal Surgery Market Overview
- 5.1.1 Spinal Surgery Market Drivers
- 5.1.2 Spinal Surgery Market Restraints
- 5.1.3 Spinal Surgery Future Outlook
5.2 Nucleus replacement Background
5.3 Nucleus Replacement History
5.4 Nucleus Replacement Drivers
- 5.4.1 Advantages over Spinal Fusion
- 5.4.2 Nucleus Replacement Superior to Total Disc Prosthesis
- 5.4.3 Strong Clinical Data Support
5.5 Nucleus Replacement Future Outlook
5.6 Nucleus Replacement Products in Pipeline
- 5.6.1 Biodisc
- 5.6.2 DASCOR Disc Arthroplasty System
- 5.6.3 DiscCell
- 5.6.4 HydraFlex Nucleus Arthroplasty System
- 5.6.5 NeoDisc
- 5.6.6 NuCore Injectable Nucleus
- 5.6.7 NUBAC Disc Arthroplasty System
- 5.6.8 Percutaneous nucleus replacement (PNR)
6 After the DES- Bioabsorbable and Prohealing Stents
6.1 Coronary Stents Market Overview
6.2 Coronary Stents Market Trend Analysis
- 6.2.1 Coronary Stents Market Drivers
- 6.2.2 Coronary Stents Market Restraints
- 6.2.3 Coronary Stents Future Outlook
6.3 Bioabsorbable and Pro-healing Stent Background
6.4 Bioabsorbable Stents
- 6.4.1 Bioabsorbable Stent Drivers
- 6.4.2 Bioabsorbable Stent Future Outlook
- 6.4.3 Bioabsorbable Stent Products in Pipeline
- 6.4.4 Bioabsorbable Stent Companies
6.5 Pro-healing Stents
- 6.5.1 Pro- healing Stent Drivers
- 6.5.2 Pro-healing Stent Future Outlook
- 6.5.3 Pro-healing Stent Products in Pipeline
- 6.5.4 Pro-Healing Stent Companies
7 Negative Pressure Wound Therapy
7.1 Advanced Wound Care Market Overview
7.2 Advanced Wound Care Trend Analysis
- 7.2.1 Advanced Wound Care Market Drivers
- 7.2.2 Advanced Wound Care Market Restraints
- 7.2.3 Advanced Wound Care Future Outlook
7.3 NPWT Background
7.4 Negative Pressure Wound Therapy Drivers
7.5 NPWT Future Outlook
7.6 Clinical Trials
7.7 NPWT Products In Pipeline
- 7.7.1 New NPWT Range Extension
7.8 NPWT Companies
8 Deep Brain Stimulation
8.1 Neurostimulation Device Market Overview
8.2 Neurostimulation Device Market Trend Analysis
- 8.2.1 Neurostimulation Device Market Drivers
- 8.2.2 Neurostimulation Device Market Restraints
- 8.2.3 Neurostimulation Device Future Outlook
8.3 Deep Brain Stimulation Background
8.4 Deep Brain Stimulation Applications
- 8.4.1 Deep Brain Stimulation for Parkinson's disease (PD)
- 8.4.2 Deep Brain Stimulation for Chronic Pain
- 8.4.3 Deep Brain Stimulation for Major Depression
8.5 Deep Brain Stimulation Drivers
8.6 Deep Brain Stimulation Future Outlook
8.7 Deep Brain Stimulation Products In Pipeline
- 8.7.1 Deep Brain Stimulation system
- 8.7.2 Renova-DT Cortical Stimulation System
- 8.7.3 NeuroStar TMS Therapy System
- 8.7.4 Deep TMS H System
- 8.7.5 Libra Deep Brain Stimulation System
- 8.7.6 Deep Brain Stimulation System for Psychiatric Disorders
8.8 Neurostimulation Companies
9 Tomosynthesis
9.1 Mammography Market Overview
9.2 Tomosynthesis Background
9.3 Tomosynthesis Drivers
- 9.3.1 Reduced Recalls
- 9.3.2 Fewer Biopsies
- 9.3.3 Improved Cancer Detection
- 9.3.4 Reduced Dose
- 9.3.5 Tissue Localization
- 9.3.6 Clearer Images
9.4 Tomosynthesis Companies
9.5 Tomosynthesis Outlook
9.6 Tomosynthesis Products in Pipeline
- 9.6.1 Breast tomosynthesis system
9.7 Digital Breast Tomosynthesis
- 9.7.1 Product Description
- 9.7.2 Product Status
10 Biologics Delivery Systems
10.1 Biologics Market Overview
10.2 Biologics Delivery Market Drivers
10.3 Biologics Delivery Future Outlook
10.4 Biologics Delivery Products in Pipeline
- 10.4.1 Myostar Catheter
- 10.4.2 Product Milestone
11 Appendix
11.1 Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panels
11.8 Contact Us
11.9 Disclaimer
1 List of Tables
Table 1: Spinal Surgery Market, Global, Revenue ($ m), 2007 2012
Table 2: Products in the Pipeline An Overview
Table 3: Biodisc Product Status
Table 4: Biodisc Product Status
Table 5: DASCOR Disc Arthroplasty System
Table 6: DASCOR Disc Arthroplasty System Description
Table 7: DASCOR Disc Arthroplasty System Clinical Trial 1
Table 8: DiscCell Product Status
Table 9: DiscCell Product Description
Table 10: DiscCell Clinical Trial 1
Table 11: DiscCell Clinical Trial 2
Table 12: HydraFlex Nucleus Arthroplasty System Product Status
Table 13: HydraFlex Nucleus Arthroplasty System Product Description
Table 14: HydraFlex Nucleus Arthroplasty System Clinical Trial
Table 15: NeoDisc Product Status
Table 16: NeoDisc Product Description
Table 17: NeoDisc Clinical Trial
Table 18: Nucore Injectable Nucleus Product Status
Table 19: Nucore Injectable Nucleus Product Description
Table 20: Nucore Injectable Nucleus Clinical Trial
Table 21: NUBAC Disc Arthroplasty System Product Status
Table 22: NUBAC Disc Arthroplasty System Product Description
Table 23: NUBAC Disc Arthroplasty System Product Clinical Trial
Table 24: Percutaneous nucleus replacement (PNR) product Status
Table 25: Percutaneous nucleus replacement (PNR) Product Description
Table 26: Category Revenues in the Global Coronary Stent Market ($ m), 2007-2012
Table 27: Fully Bioabsorbable Drug Eluting Coronary Stent Product Status
Table 28: Fully Bioabsorbable Drug Eluting Coronary Stent Product Description
Table 29: Fully Bioabsorbable Drug Eluting Coronary Stent Clinical Trial
Table 30: XTENT Bioabsorbable Stent System Product Status
Table 31: XTENT Bioabsorbable Stent System Product Description
Table 32: XTENT Bioabsorbable Stent System Product Patent Details
Table 33: Whisper Coronary Stent System Product Status
Table 34: Whisper Coronary Stent System Product Description
Table 35: Results from 12 Months E-Healing Registry
Table 36: Regenerative Stent Product Status
Table 37: Regenerative Stent Product Description
Table 38: FINALE Coated Prohealing Stent Product Status
Table 39: FINALE Coated Prohealing Stent Product Description
Table 40: Genous Bio- engineered R-Stent Product Status
Table 41: Genous Bio- engineered R-Stent Product Description
Table 42: Genous Bio- engineered R-Stent Clinical Trial
Table 43: Genous Bio- engineered R-Stent Clinical Trial 2
Table 44: Genous Bio- engineered R-Stent Patent Details
Table 45: PROTEX Coronary Stent System Product Status
Table 46: PROTEX Coronary Stent System Product Description
Table 47: Advanced Wound Care Market, US, Revenue($ m), 2000-2012
Table 48: NPWT, Potential Clinical Benefits
Table 49: Negative Pressure Wound Therapy Market, Global, Revenues ($ m), 2008-2012
Table 50: Neurostimulation Device Market, Global, Revenue by Segment ($ m), 2000-2012
Table 51: Parkinson's Disease Prevalence Rates, 2007
Table 52: Deep Brain Stimulation Market Value 2000-2012
Table 53: Deep Brain Stimulation system Product Status
Table 54: Deep Brain Stimulation system Product Description
Table 55: Deep Brain Stimulation system Clinical Trial 1
Table 56: Deep Brain Stimulation system Clinical Trial 2
Table 57: Deep Brain Stimulation system Clinical Trial 3
Table 58: Deep Brain Stimulation system Clinical Trial 4
Table 59: Renova-DT Cortical Stimulation System Product Status
Table 60: Renova-DT Cortical Stimulation System Product Description
Table 61: Renova-DT Cortical Stimulation System Clincal Trial
Table 62: NeuroStar TMS Therapy System Product Status
Table 63: NeuroStar TMS Therapy System Product Description
Table 64: NeuroStar TMS Therapy System Clinical Trial 1
Table 65: NeuroStar TMS Therapy System Clinical Trial 2
Table 66: NeuroStar TMS Therapy System Clinical Trial 3
Table 67: NeuroStar TMS Therapy System Clinical Trial 4
Table 68: Deep TMS H System Product Status
Table 69: Deep TMS H System Product Description
Table 70: Deep TMS H System Clinical Trial 1
Table 71: Deep TMS H System Clinical Trial 2
Table 72: Deep TMS H System Clinical Trial 3
Table 73: Deep TMS H System Clinical Trial 4
Table 74: Libra Deep Brain Stimulation System Product Status
Table 75: Libra Deep Brain Stimulation System Product Description
Table 76: Libra Deep Brain Stimulation System Clinical Trial 1
Table 77: Deep Brain Stimulation System for Psychiatric Disorders Product Status
Table 78: Deep Brain Stimulation System for Psychiatric Disorders Product Description
Table 79: Mammography Market, Global, 2000-2012
Table 80: Tomosynthesis Market Revenues Forecast, ($) mn, 2009-2012
Table 81: Tomosynthesis Sales Forecast, Absolute, Units, 2009-2012
Table 82: Tomosynthesis Competitive Landscape
Table 83: Myostar Catheter Product Status
Table 84: Myostar Catheter Product Description
Table 85: Myostar Catheter Clinical Trials
Table 86: Myostar Catheter Product Patent Details
1.2 List of Figures
Figure 1: Spinal Surgery Market, Global, Revenue ($ m), 2000 2012
Figure 2: Spinal Surgery Market, Company Shares (%), 2007
Figure 3: The Motion Preserving Market Segmentation, 2012
Figure 4: The Protein Based Structure Of Biodisc's Hydrogel
Figure 5: Category Revenues in the Global Coronary Stent Market ($ m), 2007-2012
Figure 6: Coronary Stents, Global, Company Share (%), 2007
Figure 7: Drug Eluting Stents Market, US, Revenue ($ m), 2003 2012
Figure 8: Coronary Stent Market Segmentation, (%), 2012
Figure 9: Prohealing stent, Comparison Results
Figure 10: Market share of Pro-healing Stents 2012
Figure 11: Advanced Wound Care Market, US, 2000-2012
Figure 12: Negative Pressure Wound Therapy A Timeline
Figure 13: Negative Pressure Wound Therapy Market, Global, Revenues ($ m), 2008-2012
Figure 14: Comparison of NPWT and AMWT
Figure 15: NPWT Company Share, Global (%), 2007
Figure 16: Neurostimulation Market Segmentation, Global, (%), 2012
Figure 17: Neurostimulation Device Market, Global, Revenue by Segment ($ m), 2000-2012
Figure 18: Deep Brain Stimulation Market Value 2000-2012
Figure 19: Neurostimulation Company Share 2007
Figure 20: Mammography Market, Global, 2000-2012
Figure 21: The Biologics Market Share of the Pharma Market, Global, 2010
Figure 22: Biologics Therapy Area Segmentation, Global, (%), 2012
Figure 23: Global Markets Direct Methodology